Utility of Some Novel Biomarkers of Patients With Chronic Heart Failure
Recruiting · NCT03772275 · Interventional (participants receive a specific treatment) · Lead sponsor: Sherief Abd-Elsalam
View the official record on ClinicalTrials.gov →Interventions studied
New york Heart Association Class INew york Heart Association Class II-IV
What this trial is about
Clinical and Economic study of some new biomarkers in chronic heart failure.
Who can take part
Age range
18 Years to 75 Years
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- NYHA-Class II-IV
Exclusion criteria
- Liver or renal dysfunction. --DM
Where it is running
1 location listed.
- Sherief Abd-Elsalam - Tanta, Elgharbia, Egypt